Adverse Effects
Ototoxicity
Illustrated example: “A 58-year-old male with underlying HFrEF and chronic kidney disease stage 4, presented with acute decompensated CCF. He was started with IV furosemide for rapid diuresis. On day 3 of admission, he complained of decline in hearing, with on and off tinnitus.”
Furosemide is a commonly used medication in patients with fluid overload. However it can lead to ototoxicity especially in:
⛽️ Very high dose of furosemide (e.g. IV Furosemide >240 mg/hour)
⛽️ Lower doses of furosemide (e.g. IV Furosemide 80 – 160 mg/hour) but concurrent use of other ototoxins such as aminoglycosides (e.g. gentamicin, amikacin) OR with impaired kidney functions (i.e. AKI / CKD)
The hearing disorder can be transient / permanent
Mechanisms of ototoxicity
⛽️ Furosemide interferes with the ion transport mechanisms in the cochlea, particularly affecting the stria vascularis, which is responsible for maintaining the ionic balance necessary for hearing
Other adverse effects of furosemide
⛽️ Hyponatraemia
⛽️ Hypokalaemia
⛽️ Hypotension
⛽️ Hyperuricaemia
⛽️ Metabolic alkalosis
Hence, we should be more aware if the patients in the ward reporting hearing disturbances while on furosemide treatment. Reduce the dose of furosemide if higher doses are not necessary.
Miscellaneous
- Furosemide (Lasix®) vial: 10 mg/mL. Example: IVI Lasix 0.5 mL/hr = 5 mg/hr = 120 mg/day = 40 mg TDS
- Furosemide 40 mg is equivalent to bumetanide 1 mg. At higher bumetanide doses, this ratio falls. Bumetanide is usually used only if the patient is unresponsive to furosemide.
References / Further Readings
- Loop diuretics: Dosing and major side effects (https://www.uptodate.com/contents/loop-diuretics-dosing-and-major-side-effects)
Keywords: frusemide, lasix
